Abstracts tagged "Systemic sclerosis and tobacco use"

Abstract Number: 1683 • 2017 ACR/ARHP Annual Meeting
Smoking Behaviour and the Progression of Organ Manifestations in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study
Veronika K. Jaeger¹, Gabriele Valentini², Eric Hachulla³, Franco Cozzi⁴, Oliver Distler⁵, Paolo Airò⁶, Lazlo Czirjak⁷, Yannick Allanore⁸, Elise Siegert⁹, Edoardo Rosato¹⁰, Marco Matucci-Cerinic¹¹, Lisa Maria Bambara¹², Joerg C. Henes¹³, Patricia Carreira¹⁴, Vanessa Smith¹⁵, Francesco Del Galdo¹⁶, Christopher Denton¹⁷, Susanne Ullman¹⁸, Ellen de Langhe¹⁹, Valeria Riccieri²⁰, Juan José Alegre²¹, Simona Rednic²², Ulf Müller-Ladner²³ and Ulrich A. Walker¹, ¹Department of Rheumatology, University Hospital Basel, Basel, Switzerland, ²Second University of Naples, Naples, Italy, ³Department of Internal Medicine, Université de Lille, Lille, France, ⁴Division of Rheumatology, Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy, ⁵Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, ⁶Rheumatology and Clinical immunology Unit, Spedali Civili of Brescia, Brescia, Italy, ⁷Department of Rheumatology and Immunology, University of Pécs, Pécs, Hungary, ⁸Department of Rheumatology, University Paris Descartes and Cochin Hospital, Paris, France, ⁹Rheumatology and Clinical Immunology, University Hospital Charité, Berlin, Germany, ¹⁰Sapienza University of Rome, Rome, Italy, ¹¹Dept of Medicine/Div of Rheum, University of Florence, Florence, Italy, ¹²University of Verona, Verona, Italy, ¹³Department of Internal Medicine II, Division of Rheumatology, University Hospital Tuebingen, Tuebingen, Germany, ¹⁴Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ¹⁵Faculty of Internal Medicine, Ghent University, Ghent, Belgium, ¹⁶Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, ¹⁷Department of Rheumatology, University College London, Royal Free Hospital, London, United Kingdom, ¹⁸Department of Dermatology, Copenhagen University Hospital, Copenhagen, Denmark, ¹⁹Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium, ²⁰Divisione di Reumatologia, Università di Roma La Sapienza, Roma, Italy, ²¹Sección de Reumatología Hospital Universitario Dr Peset Valencia, Valencia, Spain, ²²Clinica Reumatologie, University of Medicine & Pharmacy, Cluj-Napoca, Romania, ²³Justus-Liebig-University Giessen, Department of Internal Medicine and Rheumatology, Kerckhoff-Klinik, Bad Nauheim, Germany, Bad-Nauheim, Germany
Background/Purpose: Systemic sclerosis (SSc) is a rare, multisystem autoimmune disorder. It is characterized by generalized microangiopathy, in the pathogenesis of which hypoxia and oxidative stress…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].